Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting

被引：0
|
作者：
B. Muresan
C. Mamolo
J. C. Cappelleri
M. J. Postma
B. Heeg
机构：
[1] Ingress-health Netherlands,Department of Health Sciences, University Medical Center Groningen
[2] Pfizer Inc,Department of Economics, Econometrics and Finance, Faculty of Economics and Business
[3] University of Groningen,undefined
[4] University of Groningen,undefined
来源：
Applied Health Economics and Health Policy | 2021年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：929 / 940
页数：11
相关论文
共 50 条
  • [1] Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting
    Muresan, B.
    Mamolo, C.
    Cappelleri, J. C.
    Postma, M. J.
    Heeg, B.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (06) : 929 - 940
  • [2] Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune Thrombocytopenia
    Goshua, George
    Sinha, Pranay
    Pischel, Lauren
    Lee, Alfred Ian
    Cuker, Adam
    BLOOD, 2021, 138
  • [3] Bosutinib as Third-Line Treatment for Chronic Phase Chronic Myeloid Leukemia Following Failure of Second-Line Therapy with Dasatinib or Nilotinib
    Khoury, H. Jean
    Kim, Dong-Wook
    Zaritskey, Andrey
    Gambacorti-Passerini, Carlo
    Hochhaus, Andreas
    Navarro, Juan
    Rapoport, Aaron P.
    Dorlhiac-Llacer, Pedro Enrique
    Zanichelli, Maria
    Kelly, Virginia
    Besson, Nadine
    McMullan, Trevor
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    BLOOD, 2010, 116 (21) : 391 - 391
  • [4] COST-EFFECTIVENESS OF PONATINIB IN THE TREATMENT OF PATIENTS WITH CHRONIC PHASE- CHRONIC MYELOID LEUKEMIA IN GREECE
    Gourzoulidis, G.
    Kourlaba, G.
    Giannoulia, P.
    Panagiotidis, P.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A435 - A435
  • [5] BOSUTINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
    Quintas-Cardama, A.
    Kantarjian, H.
    Cortes, J.
    DRUGS OF TODAY, 2012, 48 (03) : 177 - 188
  • [6] Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase
    陈怡琳
    ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (03) : 181 - 181
  • [7] Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemia
    Whalen, John
    Stillman, Ipek
    Ambavane, Apoorva
    Felber, Eugene
    Makenbaeva, Dinara
    Bolinder, Bjorn
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (05) : 445 - 461
  • [8] Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
    Mahon, Francois-Xavier
    Boquimpani, Carla
    Kim, Dong-Wook
    Benyamini, Noam
    Clementino, Nelma Cristina D.
    Shuvaev, Vasily
    Ailawadhi, Sikander
    Lipton, Jeffrey Howard
    Turkina, Anna G.
    De Paz, Raquel
    Moiraghi, Beatriz
    Nicolini, Franck E.
    Dengler, Jolanta
    Sacha, Tomasz
    Takahashi, Naoto
    Fellague-Chebra, Rafik
    Acharya, Sandip
    Wong, Stephane
    Jin, Yu
    Hughes, Timothy P.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (07) : 461 - +
  • [9] Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
    Breccia, Massimo
    Abruzzese, Elisabetta
    Castagnetti, Fausto
    Bonifacio, Massimiliano
    Gangemi, Domenica
    Sora, Federica
    Iurlo, Alessandra
    Luciano, Luigiana
    Gozzini, Antonella
    Gentile, Massimo
    Bocchia, Monica
    Luzi, Debora
    Maggi, Alessandro
    Sgherza, Nicola
    Isidori, Alessandro
    Crugnola, Monica
    Pregno, Patrizia
    Scortechini, Anna Rita
    Capodanno, Isabella
    Pizzuti, Michele
    Foa, Robin
    ANNALS OF HEMATOLOGY, 2018, 97 (09) : 1577 - 1580
  • [10] Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
    Massimo Breccia
    Giuliana Alimena
    BioDrugs, 2011, 25 : 147 - 157
12345